Skip to main content

Corporate Presentations


  • Presentation of OncoLab Diagnostics GmbH

    an R&D company in Lower Austria
    (german)

    13.01.2021

  • Short Presentation

    OncoLab Diagnostics GmbH chose the TFZ-Wiener Neustadt as new location
    (german)

    09/2020

Press Releases


13.01.2021 – Liquid Biopsy: One-stop-shop for identifying circulating tumor cells using PCR or immunostaining

13.01.2021 – Flüssigbiopsie: Alles aus einer Hand zum Aufspüren von zirkulierenden Tumorzellen mittels PCR und Immunfärbung

19.01.2021 – Transatlantic Partnership: Axon Dx announces Transatlantic Partnership for Commercialization of nCyteDx® Platform Suite: Blood-Based Biopsy Tools for Rare Cell Detection

22.09.2021 – p53 Prions – Novel Biomarker for Circulating Tumor Cells: Patent-pending Test Kit by OncoLab Launched

Conferences & Presentations


22.09.2021 – OncoLab @ 5th ACTC – Advances in Circulating Tumor Cells “Liquid Biopsy in its best” meeting in Kalamata, Greece

OncoLab is proud to present its full product range at the 5th ACTC – Advances in Circulating Tumor Cells meeting, 22nd-25th of September 2021, in Kalamata, Greece.

For a more detailed insight in our current work you may refer to the following documentations presented at the ACTC:

Microscopic enumeration of cytokeratin (CK)-positive cells in Small Cell Lung Cancer (SCLC) using the nCyte Dx® system and evaluation of results with real-time quantitative PCR (RT-qPCR)

Longitudinal monitoring of cytokeratin (CK)-positive cells in patients with prostate cancer after radiation therapy